glp-1 cpg news adoption forces CPGs to rethink growth Caution advised for GLP-1 labeling

The protein content in GLP-1 Protein+ addresses the widely observed drop in protein consumption among users of GLP-1 treatments

In recent months, semaglutide-containing medications have grown in popularity, in part due to reported use by celebrities

Individualized riskbenefit assessment and clinical monitoring are warranted, particularly in vulnerable populations or those with complex psychiatric comorbidities

In the SURMOUNT clinical trials, participants using the highest dose (15 mg) achieved an average weight loss of approximately 1520% of their initial body weight over 72 weeks when combined with intensive lifestyle support

If you are unsure whether your medication is still good, checking semaglutide shelf life guidelines or tirzepatide shelf life information can help you make an informed decision

GLP-1 receptor agonists seem to have the unique ability to reduce these effects without completely blocking dopamine release